Analysis of outcomes in radiation oncology: An integrated computational platform

Medical Physics

Volumn 36, Issue 5, 2009, Pages 1680-1689

  Liu, Dezhi ^a   Ajlouni, Munther ^a   Jin, Jian Yue ^a   Ryu, Samuel ^a   Siddiqui, Farzan ^a   Patel, Anushka ^a   Movsas, Benjamin ^a   Chetty, Indrin J ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Biologically effective dose; Outcome study; Radiobiological model

Indexed keywords

CLINICAL RESEARCH; COMPUTER AIDED DIAGNOSIS; ONCOLOGY; RADIOTHERAPY;

BIOLOGICALLY EFFECTIVE DOSE; COMPUTATIONAL ENVIRONMENTS; COMPUTATIONAL PLATFORMS; LOCOREGIONAL CONTROL; OUTCOME STUDY; RADIATION DOSE DISTRIBUTION; RADIOBIOLOGICAL MODELING; REPRODUCIBLE RESEARCH;

DATA FLOW ANALYSIS;

ARTICLE; CANCER RADIOTHERAPY; COMPUTER ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER INTERFACE; COMPUTER MODEL; COMPUTER PROGRAM; DATA ANALYSIS; DATA BASE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; INTENSITY MODULATED RADIATION THERAPY; LUNG LESION; ONCOLOGY; OUTCOME ASSESSMENT; PATIENT INFORMATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIOBIOLOGY; STEREOTACTIC BODY RADIATION THERAPY; SYSTEM ANALYSIS; TREATMENT PLANNING;

EID: 65449179180     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3114022     Document Type: Article

References (45)

1. A. B. Jani, L. W. Davis, and T. H. Fox, " Integration of database for radiotherapy outcomes analysis.," J. Am. Coll. Radiol. 4 (11), 825-831 (2007). 10.1016/j.jacr.2007.05.020
2. W. T. McGivney and S. J. Perkel, " Oncology: Practice guidelines and outcomes measurement.," Ambul. Outreach Spring, 1998 (unpublished), pp. 17-19.
3. J. M. Galvin, " Implementing IMRT in clinical practice: A joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine.," Int. J. Radiat. Oncol., Biol., Phys. 58 (5), 1616-1634 (2004).
4. L. A. Dawson and M. B. Sharpe, " Image-guided radiotherapy: Rationale, benefits, and limitations.," Lancet Oncol. 7 (10), 848-858 (2006). 10.1016/S1470-2045(06)70904-4
5. C. C. Ling, E. Yorke, and Z. Fuks, " From IMRT to IGRT: Frontierland or Neverland?," Radiother. Oncol. 78, 119-122 (2006). 10.1016/j.radonc. 2005.12.005
6. J. O. Archambeau and R. M. Shymko, " Tissue population configuration as a modifier of organ dose response.," Int. J. Radiat. Oncol., Biol., Phys. 15 (3), 727-734 (1988).
7. C. Burman, G. J. Kutcher, B. Emami, and M. Goitein, " Fitting of normal tissue tolerance data to an analytic function.," Int. J. Radiat. Oncol., Biol., Phys. 21 (1), 123-135 (1991).
8. B. Emami, J. Lyman, A. Brown, L. Coia, M. Goitein, J. E. Munzenrider, B. Shank, L. J. Solin, and M. Wesson, " Tolerance of normal tissue to therapeutic irradiation.," Int. J. Radiat. Oncol., Biol., Phys. 21 (1), 109-122 (1991).
9. A. Jackson, G. Kutcher, and E. Yorke, " Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation.," Med. Phys. 20 (3), 613-625 (1993).
10. P. Kallman, A. Agren, and A. Brahme, " Tumour and normal tissue responses to fractionated nonuniform dose delivery.," Int. J. Radiat. Biol. 62 (2), 249-262 (1992).
11. A. Niemierko and M. Goitein, " Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture.," Radiother. Oncol. 20 (3), 166-176 (1991).
12. A. Niemierko and M. Goitein, " Modeling of normal tissue response to radiation: The critical volume model.," Int. J. Radiat. Oncol., Biol., Phys. 25 (1), 135-145 (1993).
13. T. E. Schultheiss, C. G. Orton, and R. A. Peck, " Models in radiotherapy: Volume effects.," Med. Phys. 10 (4), 410-415 (1983).
14. H. D. Thames and J. H. Hendry, Fractionation in Radiotherapy (Taylor & Francis, London, 1987).
15. H. R. Withers, J. M. Taylor, and B. Maciejewski, " Treatment volume and tissue tolerance.," Int. J. Radiat. Oncol., Biol., Phys. 14 (4), 751-759 (1988).
16. A. B. Wolbarst, " Optimization of radiation therapy II: The critical-voxel model.," Int. J. Radiat. Oncol., Biol., Phys. 10 (5), 741-745 (1984).
17. J. O. Deasy, A. I. Blanco, and V. H. Clark, " CERR: A computational environment for radiotherapy research.," Med. Phys. 30 (5), 979-985 (2003).
18. E. Spezi, D. G. Lewis, and C. W. Smith, " A DICOM-RT-based toolbox for the evaluation and verification of radiotherapy plans.," Phys. Med. Biol. 47, 4223-4232 (2002).
19. A. Alexander, F. DeBlois, G. Stroian, K. Al-Yahya, E. Heath, and J. Seuntjens, " MMCTP: A radiotherapy research environment for Monte Carlo and patient-specific treatment planning.," Phys. Med. Biol. 42, N297-N308 (2007). 10.1088/0031-9155/52/13/N03
20. J. Lehmann, " Monte Carlo treatment planning for molecular target radiotherapy within the MINERVA system.," Phys. Med. Biol. 50, 947-958 (2005).
21. O. Gayou, D. Parda, and M. Miften, " EUCLID: An outcome analysis tool for high-dimensional clinical studies.," Phys. Med. Biol. 52, 1705-1719 (2007).
22. B. Sanchez-Nieto and A. E. Nahum, " BIOPLAN: Software for the biological evaluation of radiotherapy treatment plans.," Med. Dosim. 25, 71-76 (2000). 10.1016/S0958-3947(00)00031-5
23. B. Warkentin, " TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets.," J. Appl. Clin. Med. Phys. 5, 50-63 (2004).
24. P. C. de Groen, J. A. Barry, and W. J. Schaller, " Applying world wide web technology to the study of patients with rare diseases.," Ann. Intern Med. 129 (2), 107-113 (1998).
25. E. E. Westberg and R. A. Miller, " The basis for using the internet to support the information needs of primary care.," J. Am. Med. Inform Assoc. 6 (1), 6-25 (1999).
26. M. R. Mahoney, D. J. Sargent, M. J. O'Connell, R. M. Goldberg, P. Schaefer, and J. C. Buckner, " Dealing with a deluge of data: An assessment of adverse event data on North Central Cancer Treatment Group Trials.," J. Clin. Oncol. 23 (36), 9275-9281 (2005). 10.1200/JCO.2004.00.0588
27. M. G. Herman, " Computer networking and information systems in radiation oncology.," AAPM Refresher Course (1999).
28. R. A. Dahl, " Radiation oncology information systems.," Med. Phys. 29 (6), 1364 (2002).
29. J. F. Fowler, " The linear-quadratic formula and progress in fractionated radiotherapy.," Br. J. Radiol. 62, 679-694 (1989).
30. A. Niemierko, " A generalized concept of equivalent uniform dose (EUD).," Med. Phys. 26 (6), 1100 (1999).
31. Q. Wu, R. Mohan, A. Niemierko, and R. Schmidt-Ullrich, " Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose.," Int. J. Radiat. Oncol., Biol., Phys. 52, 224-235 (2002).
32. J. T. Lyman, " Complication probability as assessed from dose volume histograms.," Radiat. Res. 8, S13-S19 (1985). 10.2307/3576626
33. G. J. Kutcher and C. Burman, " Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method.," Int. J. Radiat. Oncol., Biol., Phys. 16 (6), 1623-1630 (1989).
34. Y. Seppenwoolde, " Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability.," Int. J. Radiat. Oncol., Biol., Phys. 55, 724-735 (2003).
35. M. V. Graham, J. A. Purdy, B. Emami, W. Harms, W. Bosch, M. A. Lockett, and C. A. Perez, " Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC).," Int. J. Radiat. Oncol., Biol., Phys. 45 (2), 323-329 (1999).
36. M. Hernando, " Radiation induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer.," Int. J. Radiat. Oncol., Biol., Phys. 51 (3), 650-659 (2001).
37. J. G. Armstrong, " Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer.," Radiother. Oncol. 44, 17-22 (1997).
38. J. G. Kutcher, " Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations.," Int. J. Radiat. Oncol., Biol., Phys. 21, 136-146 (1991).
39. D. Liu, J. Jin, S. Ryu, F. Siddiqui, B. Movsas, and I. J. Chetty, " An integrated software platform for treatment documentation and outcome analysis for stereotactic radiosurgery and hypo-fractionated stereotactic body radiotherapy.," Med. Phys. 35 (6), 2639 (2008).
40. I. J. Chetty, I. Ouyang, N. Wen, D. Liu, Q. Chen, D. Babij, I. Aref, B. Movsas, and M. Ajlouni, " Assessment of target volumes and dose coverage in 4D imaging and planning of lung cancer patients treated with stereotactic body radiotherapy (SBRT).," Radiother. Oncol. 88, S30 (2008).
41. B. Georgy, " Metastatic spinal lesions: State-of-the-art treatment options and future trends.," AJNR Am. J. Neuroradiol. 29, 1605-1611 (2008). 10.3174/ajnr.A1137
42. A. Sahgal, D. Larson, and E. Chang, " Stereotactic body radiosurgery for spinal metastases: A critical review.," Int. J. Radiat. Oncol., Biol., Phys. 71 (3), 652-665 (2008).
43. D. Song, B. Kavanagh, S. Benedict, and T. Schefter, " Stereotactic body radiation therapy: Rationale, techniques, applications, and optimization.," Oncology 18 (11), 1419-1430 (2004).
44. R. Timmerman and B. Kavanagh, " Stereotactic body radiation therapy.," Curr. Probl Cancer 29 (3), 120-157 (2005). 10.1016/j. currproblcancer.2005.05.001
45. R. Timmerman, " Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.," J. Clin. Oncol. 24 (30), 4833-4839 (2006).